Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision
- A. McLellanS. Wolowacz D. Roberts
- 24 May 2011
Medicine
FLSs are cost-effective for the prevention of further fractures in fragility-fracture patients and would be expected to result in important benefits in fractures avoided and reduced hospital bed occupancy.
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.
- S. WolowaczA. Briggs R. Norman
- 1 September 2016
Economics, Medicine
The cost of illness of atrial fibrillation: a systematic review of the recent literature.
- S. WolowaczM. SamuelV. BrennanJ. Jasso-MosquedaV. Gelder
- 1 October 2011
Medicine, Economics
In this first systematic review of the economic burden of AF, hospitalizations consistently represented the major cost driver and are expected to increase in future due to ageing populations.
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery.
- S. WolowaczN. Roskell I. Brenkel
- 2009
Medicine, Economics
Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis.
- S. WolowaczD. CameronH. TateA. Bagust
- 20 February 2008
Economics, Medicine
The use of adjuvant TAC rather than FAC for node-positive early breast cancer patients is cost effective, despite the increased drug and toxicity treatment costs, and when primary G-CSF prophylaxis is given to all patients.
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement
- S. WolowaczN. Roskell I. Brenkel
- 18 December 2009
Economics, Medicine
Dabigatran etexilate 150 mg od is cost saving compared with enoxaparin 40 mg od in patients aged over 75 years and in patients with moderate renal impairment, with comparable efficacy and safety.
Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
- S. WolowaczN. RoskellS. KellyF. MaciverC. Brand
- 2012
Medicine
Pegaptanib treatment is likely to be cost effective across all groups studied, and marginally more cost effective in younger patients and those with better pre-treatment VA.
Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
- Mei GraceA. ColosiaS. WolowaczC. PanozzoParinaz K. Ghaswalla
- 11 May 2023
Medicine, Economics
The economic burden of RSV infections on healthcare systems and payers was found to be substantial, globally, underscoring the need for RSV preventive strategies for reducing this burden.
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty
- S. WolowaczN. RoskellJ. PlumbJ. CapriniB. Eriksson
- 6 December 2008
Medicine
Meta-analysis of RE-MODEL and RE-NOVATE supported the conclusions of the individual trials that dabigatran etexilate is non-inferior to enoxaparin 40 mg od, with a similar safety profile.
...
...